chr10-87727289-G-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001015880.2(PAPSS2):​c.886G>A​(p.Val296Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.012 in 1,612,812 control chromosomes in the GnomAD database, including 141 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0084 ( 5 hom., cov: 32)
Exomes 𝑓: 0.012 ( 136 hom. )

Consequence

PAPSS2
NM_001015880.2 missense

Scores

6
12

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 3.13

Publications

12 publications found
Variant links:
Genes affected
PAPSS2 (HGNC:8604): (3'-phosphoadenosine 5'-phosphosulfate synthase 2) Sulfation is a common modification of endogenous (lipids, proteins, and carbohydrates) and exogenous (xenobiotics and drugs) compounds. In mammals, the sulfate source is 3'-phosphoadenosine 5'-phosphosulfate (PAPS), created from ATP and inorganic sulfate. Two different tissue isoforms encoded by different genes synthesize PAPS. This gene encodes one of the two PAPS synthetases. Defects in this gene cause the Pakistani type of spondyloepimetaphyseal dysplasia. Two alternatively spliced transcript variants that encode different isoforms have been described for this gene. [provided by RefSeq, Jul 2008]
PAPSS2 Gene-Disease associations (from GenCC):
  • spondyloepimetaphyseal dysplasia, PAPSS2 type
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet, Ambry Genetics
  • autosomal recessive brachyolmia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.008572251).
BP6
Variant 10-87727289-G-A is Benign according to our data. Variant chr10-87727289-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 500278.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00845 (1286/152278) while in subpopulation NFE AF = 0.0142 (966/68018). AF 95% confidence interval is 0.0135. There are 5 homozygotes in GnomAd4. There are 589 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 5 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PAPSS2NM_001015880.2 linkc.886G>A p.Val296Met missense_variant Exon 9 of 13 ENST00000456849.2 NP_001015880.1 O95340-2
PAPSS2NM_004670.4 linkc.871G>A p.Val291Met missense_variant Exon 8 of 12 NP_004661.2 O95340-1Q5TB52

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PAPSS2ENST00000456849.2 linkc.886G>A p.Val296Met missense_variant Exon 9 of 13 1 NM_001015880.2 ENSP00000406157.1 O95340-2
PAPSS2ENST00000361175.8 linkc.871G>A p.Val291Met missense_variant Exon 8 of 12 1 ENSP00000354436.4 O95340-1

Frequencies

GnomAD3 genomes
AF:
0.00845
AC:
1286
AN:
152160
Hom.:
5
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00261
Gnomad AMI
AF:
0.00329
Gnomad AMR
AF:
0.00891
Gnomad ASJ
AF:
0.00923
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00124
Gnomad FIN
AF:
0.000943
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.0142
Gnomad OTH
AF:
0.0105
GnomAD2 exomes
AF:
0.00815
AC:
2046
AN:
250964
AF XY:
0.00835
show subpopulations
Gnomad AFR exome
AF:
0.00252
Gnomad AMR exome
AF:
0.00665
Gnomad ASJ exome
AF:
0.00766
Gnomad EAS exome
AF:
0.000109
Gnomad FIN exome
AF:
0.00102
Gnomad NFE exome
AF:
0.0139
Gnomad OTH exome
AF:
0.0106
GnomAD4 exome
AF:
0.0123
AC:
18002
AN:
1460534
Hom.:
136
Cov.:
32
AF XY:
0.0121
AC XY:
8797
AN XY:
726628
show subpopulations
African (AFR)
AF:
0.00266
AC:
89
AN:
33454
American (AMR)
AF:
0.00671
AC:
300
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00739
AC:
193
AN:
26134
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39690
South Asian (SAS)
AF:
0.00160
AC:
138
AN:
86204
European-Finnish (FIN)
AF:
0.00133
AC:
71
AN:
53418
Middle Eastern (MID)
AF:
0.0210
AC:
104
AN:
4958
European-Non Finnish (NFE)
AF:
0.0149
AC:
16543
AN:
1111672
Other (OTH)
AF:
0.00936
AC:
564
AN:
60280
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.455
Heterozygous variant carriers
0
881
1763
2644
3526
4407
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
616
1232
1848
2464
3080
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00845
AC:
1286
AN:
152278
Hom.:
5
Cov.:
32
AF XY:
0.00791
AC XY:
589
AN XY:
74464
show subpopulations
African (AFR)
AF:
0.00260
AC:
108
AN:
41570
American (AMR)
AF:
0.00889
AC:
136
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.00923
AC:
32
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.00124
AC:
6
AN:
4824
European-Finnish (FIN)
AF:
0.000943
AC:
10
AN:
10610
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.0142
AC:
966
AN:
68018
Other (OTH)
AF:
0.0104
AC:
22
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
67
134
202
269
336
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0129
Hom.:
53
Bravo
AF:
0.00912
TwinsUK
AF:
0.0208
AC:
77
ALSPAC
AF:
0.0174
AC:
67
ESP6500AA
AF:
0.00159
AC:
7
ESP6500EA
AF:
0.0130
AC:
112
ExAC
AF:
0.00789
AC:
958
Asia WGS
AF:
0.00202
AC:
7
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

May 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

PAPSS2: BP4, BS1, BS2 -

not specified Benign:1
Feb 21, 2017
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Spondyloepimetaphyseal dysplasia, PAPSS2 type Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.097
BayesDel_addAF
Benign
-0.51
T
BayesDel_noAF
Benign
-0.49
CADD
Uncertain
25
DANN
Uncertain
1.0
DEOGEN2
Benign
0.14
T;.
Eigen
Uncertain
0.28
Eigen_PC
Uncertain
0.39
FATHMM_MKL
Uncertain
0.91
D
LIST_S2
Uncertain
0.94
D;D
MetaRNN
Benign
0.0086
T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Uncertain
2.3
M;.
PhyloP100
3.1
PrimateAI
Benign
0.46
T
PROVEAN
Benign
-1.4
N;N
REVEL
Benign
0.056
Sift
Benign
0.071
T;T
Sift4G
Benign
0.073
T;T
Polyphen
0.46
P;P
Vest4
0.52
MVP
0.55
MPC
0.50
ClinPred
0.0083
T
GERP RS
5.7
Varity_R
0.064
gMVP
0.54
Mutation Taster
=90/10
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs45467596; hg19: chr10-89487046; API